Alzheimer

Whether enjoyed on its own or mixed into a latte, Americano or even a martini, espresso provides an ultra-concentrated jolt of caffeine to coffee lovers. But it might do more than just wake you up. Research now published in ACS' Journal of…

Lewy body disease is the second most common neurodegenerative disease after Alzheimer's disease. A research group from Lund University has now shown that the disease can be detected before symptoms appear, using a spinal fluid test. The…

Jim Sirois and his wife Sue. Jim was diagnosed with early-onset Alzheimer's more than three years ago and, since starting donanemab, his disease 'really hasn't progressed'Patients and families involved in trials of a blockbuster…

Up to one in 35 people in parts of England are thought to have dementia, according to data crunched into an interactive map by MailOnline.Charities estimate approximately 950,000 people across the country suffer with the memory-robbing…

Another breakthrough Alzheimer's drug is in the pipeline — and it could trump the two other 'game-changers'.Early trial results of remternetug are 'very promising', experts say.The drug clears the brain of amyloid, a protein that clumps…

With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease. But the drugs work best for those in the earliest stages of…

The areas of the US where Alzheimer's is most rife have been revealed — with seniors on the East Coast and South East most likely to be struck down by the memory-robbing disorder.The new report by the Alzheimer’s Association International…

The son of a man battling Alzheimer's has shared the tell-tale symptoms his dad developed 25 years ago — two decades before he was diagnosed.Richard Lindsay, 76, was only officially diagnosed with the cruel, memory-robbing disease two years…

Claims that a 'game-changing' new Alzheimer's drug can drastically slow mental decline are overblown, scientists warned today.Donanemab can thwart the memory-robbing disease's progression by up to 60 per cent, US pharma giant Eli Lilly said…

Britain's regulators are being urged to rapidly approve new Alzheimer's drugs that have been hailed as a 'turning point' in the fight against the disease.Donanemab was found to significantly delay the worsening of symptoms in people with…